EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation

Aziza A Ajlan iD, Hassan Aleid, Tariq Ali, Edward DeVol, Kris Ann Hervera Marquez, Rezqah Aldhaferi, Enaam Magzoub Karar, Amir Eltayeb Ismail Mohammed, Majid Tiba, Layal Fajji, Haifa Aldakhil, Moheeb Al-Awwami und 4 weitere

Clinical Transplantation · 2023

DOI: 10.1111/ctr.14983 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Aziza A Ajlan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Clinical Pharmacy Section, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, Kidney Transplantation. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections and the resulting disease, coronavirus disease 2019 (COVID‐19), have spread to millions of persons worldwide. Many vaccines have been developed; however, their efficacy in pediatric solid organ transplant recipients is yet to be determined.

Methods

This is a prospective observational, non‐interventional single‐center study on the safety and efficacy of a COVID‐19 vaccine (BNT162b2) in pediatric kidney transplant recipients. The primary aim of this study was to evaluate immunogenicity according to SARS‐CoV‐2‐specific neutralizing antibody titer after two vaccine doses. The secondary aims were to investigate the safety of the vaccines, solicited local and systemic adverse reactions, incidence of COVID‐19 post‐vaccination, and effects on transplant graft function. Baseline investigations were conducted on pediatric renal transplant recipients, and recruited participants were advised to have the Comirnaty® mRNA vaccine according to protocol.

Results

A total of 48 patients (male, n = 31, 64.6%; female, n = 17, 35.4%), median age 14 [12–16] years were included, and all received two doses of the vaccine. The vaccine had a favorable safety and side‐effect profile. The S‐antibody titer of all patients ranged between .4 and 2,500 U/ml and was > 50 U/ml in 89% of the patients. No difference in the measured antibody immune response was noted between infected and uninfected children. No major side effects were reported.

Conclusion

The vaccine had a favorable safety profile in 12‐ to 15‐year‐old kidney transplant recipients, producing a greater measured antibody response than that in older transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Kidney TransplantationAdolescentChildFemaleHumansMaleAntibodies, ViralBNT162 VaccineCOVID-19 VaccinesSARS-CoV-2Transplant Recipients

Stichwörter der Autor:innen

COVID19graft lossinfectionneutralizing antibodypediatricrejectionrenal transplantvaccine

Substanzen

Antibodies, ViralBNT162 VaccineCOVID-19 Vaccines

Autor:innen und Institutionen

  • Transplant Clinical Pharmacy Section, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Kidney & Pancreas Health Centre, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.
  • Department of Biostatistics, Epidemiology and Scientific Computing, King Faisal Specialist Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.
  • Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.
  • College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Saudi Society of Organ Transplantation, Riyadh, Kingdom of Saudi Arabia.

ORCID-Profile: Aziza A Ajlan

Zitieren

APA

Ajlan, A. A., Aleid, H., Ali, T., DeVol, E., Marquez, K. A. H., Aldhaferi, R., Karar, E. M., Mohammed, A. E. I., Tiba, M., Fajji, L., Aldakhil, H., Al-Awwami, M., Almslam, M. S., Assiri, A., Algoufi, T., & Broering, D. C. (2023). Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.14983

Vancouver

Ajlan AA, Aleid H, Ali T, DeVol E, Marquez KAH, Aldhaferi R, et al. Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation. Clinical Transplantation. 2023. doi:10.1111/ctr.14983

BibTeX
@article{Ajlan2023,
  author = {Ajlan, Aziza A and Aleid, Hassan and Ali, Tariq and DeVol, Edward and Marquez, Kris Ann Hervera and Aldhaferi, Rezqah and Karar, Enaam Magzoub and Mohammed, Amir Eltayeb Ismail and Tiba, Majid and Fajji, Layal and Aldakhil, Haifa and Al-Awwami, Moheeb and Almslam, Maha Saud and Assiri, Abdallah and Algoufi, Talal and Broering, Dieter C},
  title = {Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.14983}
}
Kostenlos starten →